We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$479M
AUM Growth
-$5.04M
Cap. Flow
+$8.34M
Cap. Flow %
1.74%
Top 10 Hldgs %
67.05%
Holding
98
New
1
Increased
4
Reduced
1
Closed
5

Top Buys

1
PROK icon
ProKidney
PROK
+$17.4M
2
GPGI
GPGI Inc
GPGI
+$3.2M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$547K
4
ONDS icon
Ondas Inc
ONDS
+$436K
5
LIQT icon
LiqTech
LIQT
+$267K

Top Sells

1
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.96M
2
FAZE
FaZe Holdings Inc. Common Stock
FAZE
+$2.24M
3
TEKK
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
+$990K
4
SVRE
SaverOne 2014 Ltd
SVRE
+$272K
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$31.2K

Sector Composition

1 Healthcare 21.66%
2 Consumer Discretionary 16.65%
3 Industrials 15.31%
4 Financials 13.16%
5 Materials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
26
American Express
AXP
$247B
$3.37M 0.7%
25,000
– –
JPM icon
27
JPMorgan Chase
JPM
$912B
$3.13M 0.65%
30,000
– –
HLTH
28
DELISTED
Cue Health Inc. Common Stock
HLTH
$3.01M 0.63%
1,000,000
– –
ONDS icon
29
Ondas Inc
ONDS
$3.79B
$2.87M 0.6%
775,000
+92,648
+14% +$436K
BRIV
30
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$2.2M 0.46%
225,000
– –
BRFH icon
31
Barfresh Food Group
BRFH
$29.1M
$2.1M 0.44%
725,287
– –
MXCT icon
32
MaxCyte
MXCT
$145M
$1.62M 0.34%
250,000
– –
HCAR
33
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$1.49M 0.31%
150,000
– –
FNCH
34
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$1.35M 0.28%
27,014
– –
LIQT icon
35
LiqTech
LIQT
$22.4M
$1.25M 0.26%
410,359
+69,914
+21% +$267K
CUE icon
36
Cue Biopharma
CUE
$117M
$1.24M 0.26%
18,500
– –
LBTYK icon
37
Liberty Global Class C
LBTYK
$3.52B
$1.15M 0.24%
69,618
– –
ICCC icon
38
ImmuCell
ICCC
$101M
$760K 0.16%
101,594
– –
DNTH icon
39
Dianthus Therapeutics
DNTH
$5.21B
$683K 0.14%
30,275
– –
ARKOW
40
DELISTED
ARKO Corp Warrant
ARKOW
$593K 0.12%
333,333
– –
CELC icon
41
Celcuity
CELC
$4.31B
$502K 0.1%
50,000
– –
RTX icon
42
RTX Corp
RTX
$262B
$491K 0.1%
6,000
– –
BKTI icon
43
BK Technologies
BKTI
$295M
$481K 0.1%
39,880
– –
QUMU
44
DELISTED
Qumu Corp.
QUMU
$458K 0.1%
750,000
– –
PYPL icon
45
PayPal
PYPL
$50B
$456K 0.1%
5,300
– –
LBTYA icon
46
Liberty Global Class A
LBTYA
$3.63B
$358K 0.07%
22,989
– –
LHX icon
47
L3Harris
LHX
$53B
$333K 0.07%
1,600
– –
CRIS icon
48
Curis
CRIS
$9.71M
$306K 0.06%
1,092
– –
INFI
49
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$298K 0.06%
250,000
– –
YEXT icon
50
Yext
YEXT
$546M
$268K 0.06%
60,000
– –
1
2
3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q3 2022 Portfolio in Review

As of Q3 2022, Bleichroeder LP held 98 positions worth $479M, down 1% from $484M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bleichroeder LP's Q3 2022 filing shows 1 new, 4 increased, 1 reduced and 5 closed positions. Its largest new stake was ProKidney: 2,000,000 shares worth $18M. The largest sale was Isleworth Healthcare Acquisition Corporation Common stock, an estimated $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bleichroeder LP's largest Q3 2022 buy was ProKidney: 2,000,000 shares worth $18M.
  • Bleichroeder LP added most to GPGI Inc in Q3 2022, an estimated $3.2M increase.
  • Bleichroeder LP's biggest Q3 2022 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $31.2K.
  • Bleichroeder LP fully exited Isleworth Healthcare Acquisition Corporation Common stock in Q3 2022, selling an estimated $9.96M.
  • Bleichroeder LP's ten largest holdings make up 67% of its $479M portfolio in Q3 2022.
  • Bleichroeder LP opened 1 new position and closed 5 in Q3 2022.
  • Bleichroeder LP's portfolio value fell 1% quarter-over-quarter to $479M.

Based on Bleichroeder LP's 13F filing for Q3 2022, filed 14 Nov 2022.